Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration - A report of 1 year result

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 12, 2007, Pages 1831-1836

  Lüke, Matthias ^a   Ziemssen, Focke ^a   Bartz Schmidt, Karl Ulrich ^a   Gelisken, Faik ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Age related macular degeneration; Full macular translocation; Photodynamic therapy; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA TRANSLOCATION; SCORING SYSTEM; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; PHOTOCHEMOTHERAPY; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 36348962356     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0558-9     Document Type: Article

References (20)

1. Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The beaver dam eye study. Ophthalmology 99:933-943
2. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol 117:1329-1345
3. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol 119:198-207
4. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group (2002) Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials - TAP report no. 5. Arch Ophthalmol 120:1307-1314
5. American Academy of Ophthalmology (2000) Macular translocation. Ophthalmology 107:1015-1018
6. Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B (2003) One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 87:615-621
7. Mruthyunjaya P, Stinnett SS, Toth CA (2004) Change in visual function after macular translocation with 360° retinectomy for neovascular age-related macular degeneration. Ophthalmology 111:1715-1724
8. Hewitt AW, Jeganathan SV, Kidd JE, Pesudovs K, Verma N (2006) Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Arch Clin Exp Ophthalmol 244(8):972-977
9. Armbrecht AM, Aspinall PA, Dhillon B (2004) A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. Br J Ophthalmol 88:1270-1273
10. Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA (2005) Quality of life after macular translocation with 360° peripheral retinectomy for age-related macular degeneration. Ophthalmology 112:144-151
11. Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU (2007) Full macular translocation versus photodynamic therapy with verteporfin in treatment of neovascular age-related macular degeneration: 1 year results of a prospective, controlled, randomised pilot- trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol [OnlineFirst 12 January 2007]
12. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, National Eye Visual Function Questionnaire Field Test Investigators (2001) Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 119:1050-1058
13. Stelmack JA, Stelmack TR, Massof RW (2002) Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci 43:2859-2868
14. Clemons TE, Chew EY, Bressler SB, McBee W for the AREDS Research Group (2003) National eye institute visual function questionnaire in the age-related eye disease study (AREDS). Arch Ophthalmol 121:211-217
15. Mangione CM, Berry S, Spritzer K (1998) Identifying the content area for the 51-item national eye institute visual function questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116:227-233
16. Franke GH, Esser J, Voigtländer A, Mähner N (1998) Der National Eye Institute Visual Function Questionnaire (NEI-VFQ) - Erste Ergebnisse zur psychometrischen Überprüfung eines Verfahrens zur Erfassung der Lebensqualität bei Sehbeein-trächtigten. Z Med Psychol 7:178-184
17. Mangione CM (2000) The NEI VFQ-25 scoring algorithm. http://catalog.nei.nih.gov/productcart/pc/viewPrd.asp?idcategory= 50&idproduct=60#). Cited 26 February 2007
18. Cahill MT, Banks AD, Stinnett SS, Toth CA (2005) Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 112(1):152-158
19. The Submacular Surgery Trials Research Group (2003) Responsiveness of the national eye institute visual function questionnaire to changes in visual acuity. Findings in patients with subfoveal choroidal neovascularization - SST report no. 1. Arch Ophthalmol 121:531-539
20. Michels S, Schmidt-Erfurth U, Rosenfeld PJ (2006) Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs 15(7):779-793